Harvey, Brandon
- National Institute On Drug Abuse (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,606
- Long-Funded
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.2M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#1,606
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Harvey, Brandon as a PI. Multi-PI records show the full award amount for context.
- 1ZIADA000618-07ZIAContact PICellular mechanisms of neuronal dysfunction in addiction and neurodegeneration$2.1Maward amount
- $761.9Kaward amount
- 1ZIADA000651-01ZIAContact PIDeveloping rat models of HIV-associated neurotoxicity and neuroinflammation$400Kaward amount
Award organization
Organizations that administered FY2023 awards listing Harvey, Brandon as a PI.
FY2023 award administered by National Institute On Drug Abuse ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Institute On Drug Abuse
- 2007$500K Cumulative Funding
- 2007Entered Top 50% NationallyRanked #8290
- 2008$1M Cumulative Funding
- 2009$2M Cumulative Funding
- 2011$5M Cumulative Funding
- 2011Entered Top 25% NationallyRanked #2811
- 2012Entered Top 10% NationallyRanked #1892
- 2014$10M Cumulative Funding
- 2022$25M Cumulative Funding